This topic contains a solution. Click here to go to the answer

Author Question: In the hydrogen atom the potential energy is negative, but the absolute value of the potential ... (Read 203 times)

a0266361136

  • Hero Member
  • *****
  • Posts: 538
In the hydrogen atom the potential energy is negative, but the absolute value of the potential energy:
 a. is half the kinetic energy of the electron.
  b. is equal to n2 times the kinetic energy of the electron.
  c. is equal to the kinetic energy of the electron.
  d. is twice the kinetic energy of the electron.

Question 2

In the Bohr model of the atom, the orbits where electrons move slowest:
 a. have the least radius.
  c. have the least angular momentum.
  b. have the highest energy.
  d. have the lowest energy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chevyboi1976

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

D

Answer to Question 2

B




a0266361136

  • Member
  • Posts: 538
Reply 2 on: Jul 28, 2018
Gracias!


6ana001

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library